Related Experiment Videos
Human in vitro fertilization using spermatozoa capacitated in hyperosmotic media
J C Dumoulin1, J L Evers, J P Offermans
1Department of Obstetrics and Gynaecology, Academic Hospital Maastricht, University of Limburg, The Netherlands.
Gynecologic and Obstetric Investigation
|January 1, 1990
Summary
Hyperosmotic media did not improve human sperm fertilization rates in in vitro fertilization (IVF). Sperm capacitation in a 345 mosm/kg medium significantly reduced fertilizing capacity, showing no benefit for IVF success.
Area of Science:
- Reproductive Biology
- In Vitro Fertilization (IVF)
- Sperm Physiology
Background:
- Sperm capacitation is essential for fertilization.
- Hyperosmotic conditions are sometimes explored to enhance sperm function.
- The effect of hyperosmotic media on human sperm fertilizing capacity in IVF is not fully understood.
Purpose of the Study:
- To compare the fertilizing ability of human spermatozoa capacitated in hyperosmotic versus normosmotic media during in vitro fertilization (IVF).
- To evaluate the impact of different osmolalities on sperm capacitation and subsequent oocyte fertilization.
Main Methods:
- Prospective randomized trials involving human in vitro fertilization (IVF).
- Spermatozoa were incubated in normosmotic (285 mosm/kg) or hyperosmotic media (315 or 345 mosm/kg) for 2 hours.
- Oocytes were inseminated with treated spermatozoa, and fertilizing capacity was assessed.
Main Results:
- Incubation in a 315 mosm/kg medium did not affect sperm fertilizing capacity compared to the 285 mosm/kg control.
- Incubation in a 345 mosm/kg medium significantly reduced the fertilizing capacity of human spermatozoa.
- No improvement in fertilization rates was observed with hyperosmotic media in human IVF.
Conclusions:
- Hyperosmotic media at 315 or 345 mosm/kg do not offer an advantage for sperm capacitation in human IVF.
- High osmolality (345 mosm/kg) negatively impacts sperm fertilizing ability.
- Current findings suggest avoiding hyperosmotic media for sperm preparation in human IVF protocols.